Login / Signup

Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates.

Kizzmekia S CorbettMatthew GagneDanielle A WagnerSarah O' ConnellSandeep R NarpalaDillon R FlebbeShayne F AndrewRachel L DavisBarbara FlynnTimothy S JohnstonChristopher StringhamLilin LaiDaniel ValentinAlex Van RyZackery FlinchbaughAnne P WernerJuan I MolivaManjari SriparnaSijy O'DellStephen D SchmidtCourtney TuckerAngela ChoiMatthew KochKevin W BockMahnaz MinaiBianca M NagataGabriela S AlvaradoAmy R HenryFarida LabouneChaim A SchrammYi ZhangLingshu WangMisook ChoeSeyhan Boyoglu-BarnumWei ShiEvan LambSaule T NurmukhambetovaSamantha J ProvostMitzi M DonaldsonJosue MarquezJohn-Paul M ToddAnthony CookAlan DodsonAndrew S PekoszEli BoritzAurélie PloquinNicole Doria-RoseLaurent PessaintHanne AndersenKathryn E FouldsJohn MisasiKai WuAndrea CarfiMartha C NasonJohn MascolaIan N MooreDarin K EdwardsMark G LewisMehul S SutharMario RoedererAdrian McDermottDaniel C DouekNancy J SullivanBarney S GrahamRobert A Seder
Published in: bioRxiv : the preprint server for biology (2021)
mRNA-1273 boosted nonhuman primates have increased immune responses and are protected against SARS-CoV-2 beta infection.
Keyphrases
  • sars cov
  • immune response
  • respiratory syndrome coronavirus
  • binding protein
  • toll like receptor
  • dendritic cells
  • coronavirus disease
  • inflammatory response